Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07483255 · ClinicalTrials.gov registry record · NA
A Phase II Trial of Fetal Embolization for Vein of Galen Malformation
A NA study, sponsored by Darren Orbach.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07483255 is a NA study that has not yet begun recruiting, run by Darren Orbach. The registered enrollment target is 20 participants.
The verdict
NCT07483255, a NA study, has not yet begun recruiting, sponsored by Darren Orbach.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a prospective, single-arm non-randomized interventional study of fetuses to assess the efficacy and safety of fetal embolization of VOGM. Subjects will receive a one-time study intervention of fetal embolization, at or after 34 weeks of gestation. After delivery, neurological assessments will be performed every 6 months for 2 years (adjusted for gestational age). Data will be compared to historical cohorts.
Interventions
- DEVICE Fetal embolization of vein of Galen malformation using Target XL and XXL Detachable Coils
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-05 |
| Est. Completion | 2032-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07483255
The ClinicalTrials.gov registry entry for NCT07483255 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Darren Orbach, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fetal embolization of vein of Galen malformation using Target XL and XXL Detachable Coils is the first listed.
NCT07483255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07483255 about?
NCT07483255 is a clinical study titled "A Phase II Trial of Fetal Embolization for Vein of Galen Malformation". This is a prospective, single-arm non-randomized interventional study of fetuses to assess the efficacy and safety of fetal embolization of VOGM. Subjects will receive a one-time study intervention of fetal embolization, at or after 34 weeks of gestation. After delivery, neurological assessments wil...
What is the current status of trial NCT07483255?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-05. Estimated completion is 2032-12.
What interventions are being tested in trial NCT07483255?
The interventions under investigation include: Fetal embolization of vein of Galen malformation using Target XL and XXL Detachable Coils (DEVICE).
Who is sponsoring clinical trial NCT07483255?
This trial is sponsored by Darren Orbach, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.